Peter Iversen

Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf et al. · New England Journal of Medicine · 2014 · 3K citations · Full text

Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study

Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf et al. · European Urology · 2016 · 408 citations · Full text

Urology, Oncology, Medicine +6

BICALUTAMIDE MONOTHERAPY COMPARED WITH CASTRATION IN PATIENTS WITH NONMETASTATIC LOCALLY ADVANCED PROSTATE CANCER: 6.3 YEARS OF FOLLOWUP

Peter Iversen, C. Tyrrell, Amir V. Kaisary et al. · The Journal of Urology · 2000 · 345 citations

A Randomised Comparison of ‘Casodex’<sup>TM</sup> (Bicalutamide) 150 mg Monotherapy versus Castration in the Treatment of Metastatic and Locally Advanced Prostate Cancer

CJ Tyrrell, Amir Kaisary, Peter Iversen et al. · European Urology · 1998 · 307 citations

Urology, Medicine, Clinical Trials +8

Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer

David G. McLeod, Peter Iversen, William A. See et al. · British Journal of Urology · 2005 · 279 citations